Dr Reddy’s receives DCGI approval to conduct phase 2/3 trials of Sputnik V vaccine in India
OCTOBER 17, 2020 5:26:11 PM
It is unclear at this stage how many participants will be enrolled in this trial and how many sites will be studying the vaccine's safety and ability to help develop an immune response against Covid-19.
No hay comentarios:
Publicar un comentario